Tony Trulove didnt perform and struggled to give the company direction . . . IMO.Time will tell if jardine can cut the mustard
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025